Detecting Multiple Sclerosis via breath analysis using an eNose, a pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON28252

Enrollment

100

Registered

2019-11-11

Start date

2019-03-04

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Sclerosis

Interventions

Participants will breathe through the AeonoseTM for 5 minutes.

Eligibility

Inclusion criteria

Inclusion criteria: Inclusion criteria for patients with MS: - Diagnosis MS had been confirmed by a neurologist. - Age = 18 years. Inclusion criteria control subjects: - Not suspicious of having MS. - Age = 18 years.

Exclusion criteria

Exclusion criteria: Subjects who are physically or cognitively unable to use an eNose.

Design outcomes

Primary

Measure	Time frame
Investigating whether the AeonoseTM is able to distinguish breath of patients with confirmed diagnosis of MS and control subjects without any suspicion of MS.?	—

Secondary

Measure	Time frame
Determining whether AeonoseTM patterns differ between patients with MS without medication and control subjects. Determining whether AeonoseTM patterns differ for various types of MS.?	—

Contacts

Public ContactRozemarijn Ettema

Medisch Spectrum Twente

ar.ettema@mst.nl053 4872850

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)